Halozyme Appoints Darren Snellgrove as Chief Financial Officer

P SAN DIEGO, April 30, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme” or the “Company”) today announced the appointment of Darren Snellgrove as Chief…
posteditor
posteditor
Articles: 27509

Other News